AI-generated summary
The authors report using a high-pulse-rate near-infrared laser for in vivo photoacoustic flow cytometry to detect circulating human melanoma cells, including low-pigmented cells, in preclinical studies. They describe the approach as label-free, with low background signal, and suggest it could be a source for portable clinical devices. The abstract describes these as preclinical studies and does not report participant numbers.
- Who or what was studied
- Preclinical studies in mice with human melanoma circulating cells; no human participants are reported.
- Wavelengths
- 820, 1064 nm
- Limits stated in the abstract
- The abstract describes preclinical work and does not report sample sizes, so clinical applicability is not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1064 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.